Large hippocampus detected in Long COVID and ME/CFS patients
Striking brain similarities have been detected in patients who experience Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), in particular,...
Striking brain similarities have been detected in patients who experience Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), in particular,...
Unlocking the secrets behind immune exhaustion in ME/CFS and Long COVID patients.
Researchers find overlap in long COVID and ME/CFS patients using MRI.
Researchers will track progression of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
People with Long COVID in Australia have poor health outcomes that are comparable with another emerging disease known as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Calls for new national clinical guidelines to improve the care of hundreds of thousands of Australians with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and potentially thousands more with Long Covid.
Griffith University’s research into the potential overlap between Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has received a major boost thanks to a $6.4 million grant from the Stafford Fox Medical Research Foundation.
Low-dose Naltrexone may reduce Myalgic Encephalomyelitis/Chronic Fatigue Syndrome symptoms study finds.
NHMRC funding will pave the way for diagnostic tools and therapies for ME/CFS.
Griffith University research has calculated the cost of the debilitating illness ME/CFS for the first time in Australia.